Table 1.
Affinities of 5′-Uronamide Derivatives in Radioligand Binding Assays at Rat Brain A1, A2, and A3 Receptorsa-c
![]() |
|||||||
---|---|---|---|---|---|---|---|
| |||||||
Ki (nM) or % inhibition |
|||||||
compd | R1 | R2 | Ki(A1)a | Ki(A2)b | Ki(A3)c | A1/A3 | A2/A3 |
1 d | H | NH2 | 72.6 | 120 | 1410 ± 60 | 0.051 | 0.085 |
2 d | Me | NH2 | 83.6 | 66.8 | 72 ± 16 | 1.2 | 0.93 |
3 d | Et | NH2 | 6.3 | 10.3 | 113 | 0.071 | 0.091 |
4 d | cyclopropyl | NH2 | 6.4 | 13.4 | 1600 ± 70 | 0.0040 | 0.0084 |
5 | H2NEt | NH2 | 0% (10−5) | 12.5% (10−5) | 14700 ± 2540 | >1 | >1 |
6 | t-BocNHEt | NH2 | 0% (10−5) | 0% (10−5) | 18000 ± 4270 | >1 | >1 |
7 | Me | OH | 0% (10−4) | 6.2 ± 4.2% (10−4) | 6220 ± 1220f | >10 | >10 |
8 e | Et | OH | 44% (10−4) | 31% (10−4) | 5000 | >1 | >1 |
Displacement of specific [3H]PIA binding, unless noted, in rat brain membranes expressed as Ki ± SEM in nM (n = 3).
Displacement of specific [3H]CGS 21680 binding, unless noted, in rat striatal membranes, expressed as Ki ± SEM in nM (n = 3).
Displacement of specific binding of [125I] APNEA10 or [125I]-N6-(4-amino-3-iodobenzyl)adenosine-5′-N-methyluronamide28 from membranes of CHO cells stably transfected with the rat A3-CDNA, expressed as Ki ± SEM in nM (n = 3–5).
Values at A1 and A2 receptors are taken from Bruns et al.29 Ki values at A1 receptors are vs specific binding of [3H]-N6-cyclohexyladenosine. Ki values at A2 receptors are vs specific binding of [3H]NECA in the presence of 50 nM CPA in rat striatal membranes.
Values from ref 8.
Vs[125I]-N6-(4-amino-3-iodobenzyl)adenosine-5′-N-methyluronamide.